MAVILIO, Fulvio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 21.773
AS - Asia 10.005
EU - Europa 7.786
SA - Sud America 1.284
Continente sconosciuto - Info sul continente non disponibili 342
AF - Africa 207
OC - Oceania 39
Totale 41.436
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.299
SG - Singapore 4.115
GB - Regno Unito 2.129
CN - Cina 1.990
IT - Italia 1.453
HK - Hong Kong 1.342
BR - Brasile 1.007
RU - Federazione Russa 984
VN - Vietnam 829
SE - Svezia 741
FI - Finlandia 650
DE - Germania 533
BD - Bangladesh 469
FR - Francia 335
UA - Ucraina 274
KR - Corea 256
CA - Canada 241
BG - Bulgaria 221
TR - Turchia 213
IN - India 164
ID - Indonesia 134
MX - Messico 99
NL - Olanda 96
JP - Giappone 95
AR - Argentina 93
IQ - Iraq 71
IE - Irlanda 61
AE - Emirati Arabi Uniti 54
ZA - Sudafrica 53
BE - Belgio 47
EC - Ecuador 47
CO - Colombia 40
PL - Polonia 40
ES - Italia 38
AU - Australia 36
VE - Venezuela 34
MA - Marocco 32
UZ - Uzbekistan 32
EG - Egitto 31
PK - Pakistan 31
AT - Austria 30
CL - Cile 24
PH - Filippine 24
JM - Giamaica 22
MY - Malesia 22
CR - Costa Rica 20
LT - Lituania 19
SA - Arabia Saudita 19
SI - Slovenia 19
TN - Tunisia 19
BZ - Belize 18
TH - Thailandia 16
CH - Svizzera 14
KE - Kenya 14
AZ - Azerbaigian 13
DK - Danimarca 13
DZ - Algeria 13
IR - Iran 13
BO - Bolivia 12
CZ - Repubblica Ceca 12
NP - Nepal 12
JO - Giordania 11
KZ - Kazakistan 11
LU - Lussemburgo 10
NI - Nicaragua 10
PT - Portogallo 10
PY - Paraguay 10
RO - Romania 10
TT - Trinidad e Tobago 10
TW - Taiwan 10
GR - Grecia 9
HN - Honduras 9
GT - Guatemala 8
IL - Israele 8
NG - Nigeria 8
PA - Panama 8
PE - Perù 8
DO - Repubblica Dominicana 7
ET - Etiopia 7
OM - Oman 7
UY - Uruguay 7
BY - Bielorussia 6
MD - Moldavia 6
SV - El Salvador 6
CI - Costa d'Avorio 5
PR - Porto Rico 5
SN - Senegal 5
AL - Albania 4
BH - Bahrain 4
CY - Cipro 4
EU - Europa 4
HU - Ungheria 4
PS - Palestinian Territory 4
QA - Qatar 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
AO - Angola 3
Totale 41.037
Salva come PNG Salva come JPEG
Città #
Singapore 2.954
Ashburn 2.361
Fairfield 2.046
Santa Clara 2.024
Hong Kong 1.318
Southend 1.212
Woodbridge 1.089
San Jose 1.083
Chandler 952
Houston 947
Wilmington 671
Seattle 664
Cambridge 630
Ann Arbor 596
Helsinki 562
London 555
Council Bluffs 536
Jacksonville 508
Nyköping 455
Beijing 448
Hefei 402
Dearborn 389
Los Angeles 387
Sunnyvale 371
Chicago 331
The Dalles 321
San Diego 279
Modena 245
Ho Chi Minh City 242
Seoul 226
Princeton 221
Sofia 215
New York 206
Milan 198
Hanoi 183
Salt Lake City 146
Buffalo 143
Bremen 119
Eugene 102
Shanghai 98
Dallas 94
Jakarta 91
Lauterbourg 89
Moscow 88
Elk Grove Village 78
Izmir 75
São Paulo 75
Columbus 72
Phoenix 69
Des Moines 64
Dublin 61
Rome 58
Tampa 57
Dong Ket 52
Frankfurt am Main 52
Brooklyn 47
Tokyo 47
Toronto 47
Atlanta 46
San Francisco 45
Da Nang 44
Brussels 43
Boardman 38
Redwood City 38
Redondo Beach 37
Rio de Janeiro 37
Norwalk 36
Vancouver 36
Guangzhou 34
Belo Horizonte 33
Haiphong 33
Orem 33
Burlington 32
Mexico City 32
Montreal 32
Miano 31
Baghdad 29
Bonndorf 29
Lancaster 29
Las Vegas 29
Nuremberg 28
Paris 28
Delft 27
Falls Church 27
Munich 27
Hounslow 26
Philadelphia 26
Sterling 26
Naples 25
North Bergen 25
Tashkent 25
Warsaw 25
Cairo 22
Denver 22
Dhaka 22
Kilburn 22
Miami 21
Chennai 20
Detroit 20
Melbourne 20
Totale 28.911
Salva come PNG Salva come JPEG
Nome #
Retroviral Scanning: Mapping MLV Integration Sites to Define Cell-specific Regulatory Regions 911
Epithelial stem cells in corneal regeneration and epidermal gene therapy 575
IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors 457
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 449
High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors 441
PPARδ is a ligand-dependent negative regulator of Vitamin D3-induced monocyte differentiation 419
Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. 411
HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia 411
Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination 402
Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts 388
Mechanisms of retroviral integration and mutagenesis 384
Comprehensive genomic access to vector integration in clinical gene therapy 365
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 362
Targeted gene integration in human epidermal stem cells by Zinc-finger nuclease-mediated homologous recombination. 350
Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells 343
Nuclear architecture dictates HIV-1 integration site selection 342
Dynamic Transcriptional and Epigenetic Regulation of Human Epidermal Keratinocyte Differentiation 341
Site-specific integration by the adeno-associated virus rep protein 339
Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease 334
Medicina rigenerativa e nuove frontiere terapeutiche 333
Hot spots of retroviral integrations in human CD34+ hematopoietic cells 330
A single epidermal stem cell strategy for safe ex vivo gene therapy 326
Development of a Sleeping Beauty transposon-based integration system for gene transfer in human epithelial cells 326
Definition of the transcriptional activation domains of three human HOX proteins depends on the DNA-Binding context 325
Competitive engraftment of hematopoietic stem cells genetically modified with a truncated erythropoietin receptor 325
Genome-wide definition of promoter and enhancer usage during neural induction of human embryonic stem cells 320
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates. 316
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. 315
C/EBPδ regulates cell cycle and self-renewal of human limbal stem cells. 312
Gene therapy in combination with tissue engineering to treat epidermolysis bullosa 310
Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein 307
Correction of Laminin-5 Deficiency in Human Epidermal Stem Cells by Transcriptionally Targeted Lentiviral Vectors 303
Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment 303
Site-specific integration into the human genome: Ready for clinical application? 298
Gene therapy approaches for epidermolysis bullosa 298
Gene therapy of skin adhesion disorders (mini review) 295
Tracking gene-modified T cells in vivo. 293
Stem cell plasticity: time for a reappraisal? 292
Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors 291
T Lymphocytes transduced with a lentiviral vector expressing F12-Vif are protected from HIV-1 infection in an APOBEC3G-independent manner 291
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human b-globin locus 290
Role of CD34 antigen in myeloid differentiation of human hematopoietic progenitor cells 289
Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa 288
Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID 286
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design 283
Muscle-derived hematopoietic stem cells are hematopoietic in origin 282
Collagen VII gene delivery via Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 282
Estimated comparative integration hotspots identify different behaviors of retroviral gene transfer vectors 282
Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination 282
Correction of beta-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients 278
Defining the lentiviral integrome in human hematopoietic cells 275
Integration of retroviral vectors induces minor changes in the transcriptional activity of T cells from ADA-SCID patients treated with gene therapy 270
High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors 270
Correction of murine SCID-X1 by lentiviral gene therapy using a codon-optimized IL2RG gene and minimal pretransplant conditioning 266
Long-term engraftment of single genetically modified epidermal stem cell-derived clones enables safety pre-assessment of human cutaneous gene therapy 265
Non viral gene transfer via Sleeping beauty transposon for Collagen VII delivery in human primary keratinocytes. 264
Functional dissection of a transcriptionally active, target specific Hox/Pbx complex. 262
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapy 262
Bone-marrow transplantation - Failure to correct murine muscular dystrophy 261
Gene therapy of inherited skin adhesion disorders: a critical overview 260
Transcriptional targeting of lentiviral vectors by LTR enhancer replacement 254
Towards a gene therapy clinical trial for epidermolysis bullosa 254
The recruitment of SOX/OCT complexes and the differential activity of HOXA1 and HOXB1 modulate the Hoxb1 auto-regulatory enhancer function 253
The future of gene therapy 252
Genome-wide analysis of alpharetroviral integration in human hematopoietic stem/progenitor cells 248
Interactions between Retroviruses and the Host Cell Genome 246
Myogenic stem cells from the bone marrow: a therapeutic alternative for muscular dystrophy? 244
Gene therapy prolongs survival and restores function in murine and canine models of myotubular myopathy 244
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome 238
Clonal analysis of stably transduced human epidermal stem cells in culture. 236
Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells 235
RD2-molpack-chim3, a packaging cell line for stable production of lentiviral vectors for Anti-HIV gene therapy 229
Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements 227
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy 227
Toward gene therapy of junctional epidermolysis bullosa (JEB) 225
Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study 224
An Optimized Lentiviral Vector Efficiently Corrects the Human Sickle Cell Disease Phenotype 224
Safety of retroviral gene marking with a truncated NGF receptor 223
Towards the correction of genetic defect in corneal keratinocytes from patient with macular corneal Dystrophy type II 222
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 218
Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? 218
Developing gene and cell therapies for rare diseases: An opportunity for synergy between academia and industry 215
Efficient Non-viral Gene Delivery into Human Hematopoietic Stem Cells by Minicircle Sleeping Beauty Transposon Vectors 214
Translating the genomics revolution: The need for an international gene therapy consortium for monogenic diseases 212
Gene therapies need new development models 210
Preclinical corrective gene transfer in xeroderma pigmentosum human skin stem cells 207
Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency 206
Differential and stage-related expression in embryonic tissues of a new human homoeobox gene 205
Repairing without cutting: A safer alternative to gene correction? 204
Genetic modification of somatic stem cells. The progress, problems and prospects of a new therapeutic technology 202
Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia 200
Perspectives on Best Practices for Gene Therapy Programs 199
Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult 199
Designing lentiviral vectors for gene therapy of genetic diseases 195
A human homoeo box gene specifically expressed in spinal cord during embryonic development 194
Erratum: Genomic analysis of sleeping beauty transposon integration in human somatic cells (PLoS ONE (2014) 9:11 (e112712) DOI: 10.1371/journal.pone.0112712) 193
A novel homeo-domain protein, prep 1, forms a regulatory complex with pbx proteins in vivo 189
Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs 187
Two human homeobox genes, c1 and c8: Structure analysis and expression in embryonic development 180
An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency 174
Totale 28.756
Salva come PNG Salva come JPEG
Categoria #
all - tutte 194.946
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 194.946
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.930 0 0 213 187 83 353 166 190 403 379 608 348
2022/20232.948 356 286 243 229 384 424 46 287 398 32 141 122
2023/20242.759 82 103 93 168 345 235 253 678 144 154 172 332
2024/20256.512 187 55 68 494 1.324 934 338 365 789 471 710 777
2025/202613.855 701 445 866 1.380 2.794 945 1.691 696 1.292 1.252 1.011 782
2026/20272.116 478 1.360 278 0 0 0 0 0 0 0 0 0
Totale 41.436